MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, SYRE has $777,781K in assets. $62,545K in debts. $85,721K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1325.35%
Quick Ratio
1325.35%
Cash Ratio
146.07%
Debt to Asset Ratio
8.04%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Other non-current assets
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Preferred stock-Series ANon Voti...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
85,721
Marketable securities
670,812
Prepaid expenses and other current assets
21,248
Total current assets
777,781
Other non-current assets
0
Total assets
777,781
Accounts payable-Nonrelated Party
8,904
Cvr liability
22,820
Accrued and other current liabilities
26,947
Related party accounts payable-Related Party
14
Total current liabilities
58,685
Non-current cvr liability
3,860
Total liabilities
62,545
Preferred stock-Series ANon Voting Convertible Preferred Stock
146,425
Preferred stock-Series BNon Voting Convertible Preferred Stock
9,395
Preferred stock-Preferred Stock Excluding Series AAnd BNon Voting Convertible Preferred Stock
0
Common stock, 0.0001 par value 400,000,000 shares authorized as of december31, 2025 and december31, 2024 78,189,811 shares and 60,257,023 shares issued and outstanding as of december31, 2025 and december31, 2024, respectively
15
Additional paid-in capital
1,686,167
Accumulated other comprehensive income
869
Accumulated deficit
-1,127,635
Total convertible preferred stock and stockholders equity
715,236
Total liabilities, convertible preferred stock and stockholders equity
777,781
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$670,812K Cash and cashequivalents$85,721K Prepaid expenses andother current assets$21,248K Total current assets$777,781K Total assets$777,781K Total liabilities,convertible preferred stock...$777,781K Total convertiblepreferred stock and...$715,236K Total liabilities$62,545K Accumulated deficit-$1,127,635K Additional paid-in capital$1,686,167K Total currentliabilities$58,685K Non-current cvr liability$3,860K Preferred stock-SeriesANon Voting...$146,425K Preferred stock-SeriesBNon Voting...$9,395K Accumulated othercomprehensive income$869K Common stock, 0.0001par value...$15K Accrued and othercurrent liabilities$26,947K Cvr liability$22,820K Accountspayable-Nonrelated Party$8,904K Related party accountspayable-Related Party$14K

Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics, Inc. (SYRE)